Patent details

EP3777834 Title: SYRINGE

Basic Information

Publication number:
EP3777834
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP201989217
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SYRINGE
French Title of Invention:
SERINGUE
German Title of Invention:
SPRITZE
SPC Number:

Dates

Filing date:
30/05/2013
Grant date:
16/02/2022
EP Publication Date:
17/02/2021
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/02/2022
EP B1 Publication Date:
16/02/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
30/05/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
09/02/2022
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
BUETTGEN, Heinrich
Address:
Switzerland (CH)

2

Name:
PAPST, Wolfgang
Address:
Switzerland (CH)

3

Name:
BRYANT, Andrew
Address:
Switzerland (CH)

4

Name:
PICCI, Marie
Address:
Switzerland (CH)

Priority

Priority Number:
12170628
Priority Date:
01/06/2012
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 9/00; A61M 5/28; A61M 5/31; A61M 5/315; A61P 43/00; A61P 27/02;

Publication

European Patent Bulletin

Issue number:
202207
Publication date:
16/02/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
01/06/2026
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
16/05/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages